Associate Professor Belamy-Bin Cheung
Academic and Professional Qualifications:
- 2004: Doctor of Philosophy, School of Women's and Children's Health, Medicine Faculty, University of New South Wales, Australia. (Awarded on 18/5/2004)
- 1994: Master of Science, School of Pathology, Medicine Faculty, University of New South Wales, Australia.
- 1983: Bachelor of Medicine, Sun Yat-Sen University of Medical Science, Guangzhou, P. R. China.
Associate Professor Belamy Cheung, BMed, MSc, PhD
-
Principal Scientist and Research Manager, Embryonal Cancer Therapy and Prevention
-
Children’s Cancer Institute Australia
-
Lowy Cancer Research Centre, University of NSW
-
Conjoint Associate Professor, the Faculty of Medicine & Health, UNSW Sydney
A/Prof Belamy Cheung is internationally regarded as a childhood cancer researcher with a strong established track record. She has more than 70 publications in childhood cancer re...
Associate Professor Belamy Cheung, BMed, MSc, PhD
-
Principal Scientist and Research Manager, Embryonal Cancer Therapy and Prevention
-
Children’s Cancer Institute Australia
-
Lowy Cancer Research Centre, University of NSW
-
Conjoint Associate Professor, the Faculty of Medicine & Health, UNSW Sydney
A/Prof Belamy Cheung is internationally regarded as a childhood cancer researcher with a strong established track record. She has more than 70 publications in childhood cancer research. As the Principal Scientist and Program Manager at Children's Cancer Institute Australia, she leads a highly productive research team of 15 staff and students. A/Prof Cheung has successfully conducted more than 30 projects in combination therapy, MYCN biology and prevention for embryonal cancer with greater than AUS$4.5 million of sourced funding. She also has outstanding research supervision skills, having supervised more than 40 postgraduate and undergraduate students in total with a 100% completion rate. A/Prof Cheung has extensive experience in neuroblastoma biology and drug development which has been demonstrated in her publications in high quality journals, including Nature Communications, 2021, 2019a & 2019b; Cancer Research, 2019 & 2018 and Science Translational Medicine 2019 & 2015. A/Prof Cheung directs and drives the research in all three themes in the Embryonal Cancer Therapy and Prevention Program: identification of oncogenic proteins in MYC-driven cancers; developing inhibitors for MYC oncoproteins; and developing childhood cancer prevention strategies.
Contact details:
Dr Belamy Cheung, MD, MSc, PhD
Principal Scientist, Embryonal Cancer Therapy and Prevention
Conjoint Associate Professor, the Faculty of Medicine & Health, UNSW Sydney
Children's Cancer Institute
Lowy Cancer Research Centre, UNSW Australia
PO Box 81 Randwick 2031 Australia
P: 02 7209 6762 | F: 02 9662 6584 | E: BCheung@ccia.org.au | W: www.ccia.org.au
- Publications
- Grants
- Awards
- Research Activities
- Teaching and Supervision
-
Project Grant, Cancer Council NSW, Application titled: “Therapeutic and preventative strategies for children with high-risk neuroblastoma: targeting high fat diet-related metabolism", 2022-2024, $$445,006.
-
Project Grant, Cancer Council NSW, Application titled: “A novel combination therapy for childhood cancer” 2021-2023, $424,796.
-
Project Grant, the Trustees of the Anthony Rothe Memorial Trust, Application titled “Targeting PA2G4 as a novel treatment strategy for leukaemia and lymphoma". $115,000 per annum, 2020–2021.
-
Project Grant, Kids Cancer Alliance NSW, Application title “Prevention of Child Cancer – Down Syndrome”. Total of $160,000. 2018-2019.
-
NHMRC Project Grant , Application title “Therapeutic targeting of MYCN oncoprotein stability in neuroblastoma”. $590,206.20. 2017-2019.
-
UNSW Goldstar Award 2016, Proposal Title: Therapeutic targeting of the MYCN oncogenic signal in childhood neuroblastoma by inhibition of transcriptional elongation complex, FACT”. $40,000
-
Project Grant, CCIA Drug Screening Fund, titled “Identification of novel compounds which enhance the retinoid anti-cancer signal using a high-content TRIM16 translocation assay”. 2012, $10,000
-
Project Grant, Faculty of Medicine, University of NSW, project title: “Overcoming histone deacetylase inhibitor and retinoid drug resistance through novel combination therapies”, 2011, $11,000
-
Early Career Development fellowship, Cancer Institute NSW, 2007-2009, $570, 000
-
Project grant, Cure Cancer Australia, 2007, $75, 000
- 1. Australia Postgraduate Research Award, 1990-1992
- 2. Early Career Research Awards, Faculty of Medicine, UNSW, Sydney, 2005
- 3. Early Career Development fellowship Award, Cancer Institute NSW, 2007
- 4. The Institute Award for outstanding service, Children’s Cancer Institute Australia, 2010
- 5. Goldstar Award for a research project, UNSW Sydney, 2016
- 6. Travel grant, School of Life Sciences and Technology, Shanghai Tongji University, China. 2017.
Current Research Projects:
1. Developing inhibitors for MYC and MYCN oncoproteins.
2. Identification of co-factors for MYCN oncoprotein.
3. Establishing novel combination therapies for the treatment of high-risk and MYC-driven cancers.
4. Developing childhood cancer prevention strategies.
My Teaching
As a Facilitator for Scenario Groups at the Faculty of Medicine, UNSW